Pharma BD Deal Intelligence

Orchid BioSciences Inc. / AstraZeneca (Cellmark Diagnostics unit)

2001 · Asset Purchase · Complete

Announcement Sentiment
75
Strongly positive

Carve-out of AZ's UK forensic/genetic-identity diagnostics business. Financial terms were not disclosed.

Key facts

See the full interactive analysis, sources & comparables →

← Browse all deals  ·  How we score deals